pages:
-
A Pilot Study to Determine the Safety of Argatroban Injection in Combination with rt-PA in Patients with Acute Ischemic Stroke
-
A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
-
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
-
A Pragmatic Trial to Evaluate the Intermediate-Term Effects of Early, Aggressive Versus Escalation Therapy in People with Multiple Sclerosis
(Traditional versus Early Agressive Therapy for Multiple Sclerosis (TREAT-MS) Trial
-
A Pragmatic Video Intervention to Promote African American Organ Donor Registration at the Department of Motorized Vehicles
-
A Prognostic Study of Sentinel Node & Bone Marrow Micrometastases in Women with Clinical T1 or T2 NO Breast Cancer (ACOSOG)
-
A Project to Assess the Turkana Basin Using Air and Space-Based Remote Sensing Tools
-
A Proof of Concept, Randomized, Controlled Study of Tuberculosis Immunization with BCG to Prevent Infection in Healthy Adults
-
A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer - TBCRC 013 / UAB 0953
-
A Prospective Cohort Study of Cryptococcus
-
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer
-
A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders/ PBMTC PIDTC #6901
-
A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders/ PBMTC PIDTC #6901
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study)
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study) (PROMISE-OB-18)
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (the PROMISE Study) (PROMISE-OB-18)
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)
-
A Prospective Study to Evaluate Effects of Corrected CFTR Function (BEGIN)
-
A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interforn Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects: Boceprevir, Interferon, Ribavirin to Treat HCV/HIV/Coinfected Subjects (BIRTH)
-
A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women (“Pravastatin”).
-
A Randomized Controlled Trial of Regional versus General Anesthesia for Promoting Independence After Hip Fracture (REGAIN Trial)
-
A Randomized Controlled Trial of Rituximub versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)
-
A Randomized Controlled Trial of Women Involved in Supporting Health (WISH), a Peer-Led Intervention to Improve Postpartum Retention in HIV Care
-
A Randomized Controlled Trial of Woment Involved in Supporting Health (WISH), a Peer-Led Intervention to Improve Postpartum Retention in HIV Care
-
A Randomized Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs. Cyclophosphamide Alone in the Treatment of Lupus Nephritis - The Start Up Phase of Clinical Trial ITN #INT034AI
-
A Randomized Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
-
A Randomized Multi-Center Phase III Study of Individualized Sterotactic Body Radiation Therapy (SRBT) versus Trans-Arterial Chemoembolization (TACE) as a Bridge to Transplant in Hepatocellular Carcinoma
-
A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in
Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial (Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance)
-
A Randomized Phase II Trial of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Surgical Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF-1)
-
A Randomized Phase III Study Comparing Conventional Dose Treatment using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age (IFM/DFCI 2009)
pages:
